Product Description
Pegylated G-CSF Inhibits Blood Cell Depletion, Increases Platelets, Blocks Splenomegaly, and Improves Survival after Whole-Body Ionizing Irradiation but Not after Irradiation Combined with Burn - PMC Skip to main content. An official website of the United States government.How Leupag WorksLeupag stimulates the bone marrow to enhance the production of neutrophils, a type of white blood cell essential for fighting infections. This mechanism is particularly valuable for cancer patients who are at increased risk of neutropenia, especially during chemotherapy. By elevating neutrophil counts, Leupag helps to minimize the likelihood of infection, supporting more effective and uninterrupted cancer treatment regimens.
Usage and Administration GuidelinesLeupag should only be used as directed by a qualified healthcare professional. The recommended dosage is a single 6 mg subcutaneous injection per chemotherapy cycle. Before administration, the lyophilized powder must be reconstituted with the provided sterile water for injection. Strictly follow your physician's instructions, including correct reconstitution and injection practices, to ensure safety and effectiveness.
Storage, Stability, and HandlingThis biological product remains stable for up to 24 months when stored at 2C to 8C. Leupag must not be frozen and should be kept away from light until use. Each box contains one vial, ensuring precise dosing and minimizing contamination. Always check the manufacturing date and do not use past the stated shelf life for optimal results.
FAQ's of PEGYLATED (rHu G-CSF):
Q: How does Leupag (PEGYLATED rHu G-CSF) benefit cancer patients undergoing chemotherapy?
A: Leupag stimulates the bone marrow to increase neutrophil production, significantly reducing the risk of neutropenia and subsequent infections in patients undergoing chemotherapy. This enables patients to follow their prescribed treatment schedule more safely.
Q: What is the recommended process for reconstituting and administering Leupag?
A: Leupag should be reconstituted using the sterile water provided in the packaging. After complete dissolution, it is administered as a single subcutaneous injection, typically at a dose of 6 mg per chemotherapy cycle, strictly as per your healthcare provider's directions.
Q: When should Leupag be administered during chemotherapy?
A: Leupag is usually given once per chemotherapy cycle, following your physician's advice. The timing of the injection in relation to chemotherapy is critical, so always adhere to your healthcare provider's instructions for scheduling.
Q: Where should Leupag be stored and how should it be handled?
A: Store Leupag at temperatures between 2C to 8C and keep the vial protected from light. Do not freeze the product. Handle the vial with care during reconstitution and administration to maintain sterility.
Q: What precautions and contraindications should be observed with Leupag?
A: Leupag is contraindicated in individuals with known hypersensitivity to Pegfilgrastim or Filgrastim. Inform your healthcare provider about allergies and follow their guidance. Common side effects may include bone pain, headaches, or reactions at the injection site.
Q: Who is Leupag intended for and is it suitable for all adults?
A: Leupag is intended for adult patients undergoing chemotherapy who are at risk of developing neutropenia. It should be used only under medical supervision and is not recommended for individuals with hypersensitivity to its ingredients.